Sabrina Touchet

Title: Sabrina Touchet: Innovator in NMDA Receptor Modulation

Introduction

Sabrina Touchet is a prominent inventor based in Vandoeuvre-les-Nancy, France. She has made significant contributions to the field of neuroscience through her innovative research and development of pharmaceutical compositions targeting NMDA receptors.

Latest Patents

Sabrina holds a patent for "NMDA receptor modulators, compositions comprising same and use of these compounds in the treatment of diseases involving the central nervous system." This invention focuses on compounds of 1-(indol-3-yl)-3-hydroxy-3-(2-oxo-2-ethyl)-indol-2-ones type, which are intended for the prevention and treatment of various diseases related to NMDA receptors. These include severe/resistant epilepsy, cognitive disorders such as autism, strokes, schizophrenia, and degenerative diseases like Parkinson's and Alzheimer's disease, among others. She has 1 patent to her name.

Career Highlights

Sabrina is currently associated with Adpuerivitam, where she continues her research and development efforts. Her work is pivotal in advancing treatments for conditions that affect the central nervous system.

Collaborations

Sabrina collaborates with notable colleagues, including Mouad Alami and Jean Daniel Brion, who contribute to her research initiatives and projects.

Conclusion

Sabrina Touchet's innovative work in NMDA receptor modulation showcases her dedication to improving treatments for complex neurological conditions. Her contributions are vital in the ongoing quest for effective therapies in the field of neuroscience.